{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T14:07:19Z","timestamp":1790690839393,"version":"4.1.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,28]],"date-time":"2024-11-28T00:00:00Z","timestamp":1732752000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007867","name":"Universit\u00e9 Laval","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007867","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["311201"],"award-info":[{"award-number":["311201"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000156","name":"Quebec Health Research Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000156","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013367","name":"Fondation Jean-Louis L\u00e9vesque","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013367","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001677","name":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001677","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015115","name":"Fondation de l\u2019Universit\u00e9 Laval","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015115","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","jogc.com","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Obstetrics and Gynaecology Canada"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.jogc.2024.102732","type":"journal-article","created":{"date-parts":[[2024,12,2]],"date-time":"2024-12-02T17:04:27Z","timestamp":1733159067000},"page":"102732","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["First-Trimester PlGF and PAPP-A and the Risk of Placenta-Mediated Complications: PREDICTION Prospective Study"],"prefix":"10.1016","volume":"47","author":[{"given":"Marie-Laurence","family":"C\u00f4t\u00e9","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yves","family":"Gigu\u00e8re","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Claude","family":"Forest","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francois","family":"Audibert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo Ann","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Okun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Guerby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise","family":"Ghesquiere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6936-4369","authenticated-orcid":false,"given":"Emmanuel","family":"Bujold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jogc.2024.102732_bib1","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0140-6736(20)32335-7","article-title":"Pre-eclampsia","volume":"398","author":"Chappell","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.jogc.2024.102732_bib2","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1515\/jpm.2011.098","article-title":"Placental lesions associated with maternal underperfusion are more frequent in early-onset than in late-onset preeclampsia","volume":"39","author":"Ogge","year":"2011","journal-title":"J\u00a0Perinat Med"},{"key":"10.1016\/j.jogc.2024.102732_bib3","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.ajog.2019.05.044","article-title":"Placental bed research: I. The placental bed: from spiral arteries remodeling to the great obstetrical syndromes","volume":"221","author":"Brosens","year":"2019","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jogc.2024.102732_bib4","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1067\/mob.2002.127720","article-title":"Failure of physiologic transformation of the spiral arteries in the placental bed in preterm premature rupture of membranes","volume":"187","author":"Kim","year":"2002","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jogc.2024.102732_bib5","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1067\/S0002-9378(03)00838-X","article-title":"Failure of physiologic transformation of the spiral arteries in patients with preterm labor and intact membranes","volume":"189","author":"Kim","year":"2003","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jogc.2024.102732_bib6","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.ajog.2017.11.561","article-title":"Aspirin for the prevention of preterm and term preeclampsia: systematic review and metaanalysis","volume":"218","author":"Roberge","year":"2018","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jogc.2024.102732_bib7","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1097\/AOG.0b013e3181e9322a","article-title":"Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy: a meta-analysis","volume":"116","author":"Bujold","year":"2010","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jogc.2024.102732_bib8","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1056\/NEJMoa1704559","article-title":"Aspirin versus placebo in pregnancies at high risk for preterm preeclampsia","volume":"377","author":"Rolnik","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jogc.2024.102732_bib9","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0140-6736(19)32973-3","article-title":"Low-dose aspirin for the prevention of preterm delivery in nulliparous women with a singleton pregnancy (ASPIRIN): a randomised, double-blind, placebo-controlled trial","volume":"395","author":"Hoffman","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.jogc.2024.102732_bib10","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1002\/uog.12421","article-title":"Prevention of perinatal death and adverse perinatal outcome using low-dose aspirin: a meta-analysis","volume":"41","author":"Roberge","year":"2013","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.jogc.2024.102732_bib11","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.jogc.2022.03.002","article-title":"Guideline No. 426: Hypertensive disorders of pregnancy: diagnosis, prediction, prevention, and management","volume":"44","author":"Magee","year":"2022","journal-title":"J\u00a0Obstet Gynaecol Can"},{"key":"10.1016\/j.jogc.2024.102732_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajogmf.2023.101000","article-title":"Comparing Aspirin 75 to 81 mg vs 150 to 162 mg for prevention of preterm preeclampsia: systematic review and meta-analysis","volume":"5","author":"Ghesquiere","year":"2023","journal-title":"Am J Obstet Gynecol MFM"},{"key":"10.1016\/j.jogc.2024.102732_bib13","first-page":"515","volume":"38","author":"Tailor","year":"2024"},{"key":"10.1016\/j.jogc.2024.102732_bib14","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ajog.2016.09.076","article-title":"The role of aspirin dose on the prevention of preeclampsia and fetal growth restriction: systematic review and meta-analysis","volume":"216","author":"Roberge","year":"2017","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jogc.2024.102732_bib15","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1055\/s-0044-1782676","article-title":"Comparison of national factor-based models for preeclampsia screening","volume":"41","author":"Ghesqui\u00e8re","year":"2024","journal-title":"Am J Perinatol"},{"key":"10.1016\/j.jogc.2024.102732_bib16","first-page":"1022","article-title":"Aspirin at 75 to 81 mg daily for the prevention of preterm pre-eclampsia: systematic review and meta-analysis","volume":"13","author":"Demuth","year":"2024","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.jogc.2024.102732_bib17","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1159\/000341264","article-title":"Competing risks model in early screening for preeclampsia by biophysical and biochemical markers","volume":"33","author":"Akolekar","year":"2013","journal-title":"Fetal Diagn Ther"},{"key":"10.1016\/j.jogc.2024.102732_bib18","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1161\/HYPERTENSIONAHA.123.22584","article-title":"Prospective validation of first-trimester screening for preterm preeclampsia in nulliparous women (PREDICTION study)","volume":"81","author":"Guerby","year":"2024","journal-title":"Hypertension"},{"key":"10.1016\/j.jogc.2024.102732_bib19","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.jogc.2023.04.002","article-title":"Preparing to predict and prevent preeclampsia in Canada","volume":"45","author":"Bujold","year":"2023","journal-title":"J\u00a0Obstet Gynaecol Can"},{"key":"10.1016\/j.jogc.2024.102732_bib20","doi-asserted-by":"crossref","first-page":"E1557","DOI":"10.1503\/cmaj.230620","article-title":"Screening for preeclampsia risk and prophylaxis with acetylsalicylic acid","volume":"195","author":"Jain","year":"2023","journal-title":"CMAJ"},{"key":"10.1016\/j.jogc.2024.102732_bib21","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1159\/000514201","article-title":"Placental growth factor and adverse obstetric outcomes in a mixed-risk cohort of women screened for preeclampsia in the first trimester of pregnancy","volume":"48","author":"Ekelund","year":"2021","journal-title":"Fetal Diagn Ther"},{"key":"10.1016\/j.jogc.2024.102732_bib22","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/pd.5001","article-title":"Association of serum PAPP-A levels in first trimester with small for gestational age and adverse pregnancy outcomes: systematic review and meta-analysis","volume":"37","author":"Morris","year":"2017","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.jogc.2024.102732_bib23","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1111\/1471-0528.17096","article-title":"Serum PlGF compared with PAPP-A in first trimester screening for preterm pre-eclampsia: adjusting for the effect of aspirin treatment","volume":"129","author":"Wright","year":"2022","journal-title":"BJOG"},{"key":"10.1016\/j.jogc.2024.102732_bib24","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1002\/uog.19112","article-title":"Screening for pre-eclampsia by maternal factors and biomarkers at 11\u201313 weeks\u2019 gestation","volume":"52","author":"Tan","year":"2018","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.jogc.2024.102732_bib25","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1159\/000487301","article-title":"First-trimester placental growth factor for the prediction of preeclampsia in nulliparous women: the great obstetrical syndromes cohort study","volume":"45","author":"Boutin","year":"2019","journal-title":"Fetal Diagn Ther"},{"key":"10.1016\/j.jogc.2024.102732_bib26","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.1161\/HYPERTENSIONAHA.123.21568","article-title":"Maternal first-trimester alpha-fetoprotein and placenta-mediated pregnancy complications","volume":"80","author":"Melamed","year":"2023","journal-title":"Hypertension"},{"key":"10.1016\/j.jogc.2024.102732_bib27","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.ajog.2020.04.007","article-title":"How to calculate the risk of preeclampsia in women with a history of positive screening","volume":"223","author":"Guerby","year":"2020","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jogc.2024.102732_bib28","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jogc.2020.06.011","article-title":"First-trimester preterm preeclampsia screening in nulliparous women: the great obstetrical syndrome (GOS) study","volume":"43","author":"Boutin","year":"2021","journal-title":"J\u00a0Obstet Gynaecol Can"},{"key":"10.1016\/j.jogc.2024.102732_bib29","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1002\/pd.2505","article-title":"Prediction of adverse pregnancy outcomes by combinations of first and second trimester biochemistry markers used in the routine prenatal screening of Down syndrome","volume":"30","author":"Huang","year":"2010","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.jogc.2024.102732_bib30","first-page":"899","article-title":"Low pregnancy-associated plasma protein A level in the first trimester","volume":"60","author":"Huynh","year":"2014","journal-title":"Can Fam Physician"}],"container-title":["Journal of Obstetrics and Gynaecology Canada"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1701216324005553?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1701216324005553?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T02:50:30Z","timestamp":1740624630000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1701216324005553"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["S1701216324005553"],"URL":"https:\/\/doi.org\/10.1016\/j.jogc.2024.102732","relation":{},"ISSN":["1701-2163"],"issn-type":[{"value":"1701-2163","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"First-Trimester PlGF and PAPP-A and the Risk of Placenta-Mediated Complications: PREDICTION Prospective Study","name":"articletitle","label":"Article Title"},{"value":"Journal of Obstetrics and Gynaecology Canada","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jogc.2024.102732","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author. Published by ELSEVIER INC. on behalf of The Society of Obstetricians and Gynaecologists of Canada\/La Soci\u00e9t\u00e9 des obst\u00e9triciens et gyn\u00e9cologues du Canada.","name":"copyright","label":"Copyright"}],"article-number":"102732"}}